KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nu Skin Enterprises (NUS) Change in Inventory (2016 - 2025)

Nu Skin Enterprises' Change in Inventory history spans 17 years, with the latest figure at -$884000.0 for Q4 2025.

  • For Q4 2025, Change in Inventory rose 83.54% year-over-year to -$884000.0; the TTM value through Dec 2025 reached -$11.9 million, up 60.79%, while the annual FY2025 figure was -$11.9 million, 60.79% up from the prior year.
  • Change in Inventory for Q4 2025 was -$884000.0 at Nu Skin Enterprises, down from -$94000.0 in the prior quarter.
  • Across five years, Change in Inventory topped out at $53.8 million in Q1 2021 and bottomed at -$17.2 million in Q1 2022.
  • The 5-year median for Change in Inventory is -$489000.0 (2025), against an average of $5.0 million.
  • The largest annual shift saw Change in Inventory soared 3153.14% in 2021 before it plummeted 251.31% in 2024.
  • A 5-year view of Change in Inventory shows it stood at $17.2 million in 2021, then decreased by 21.55% to $13.5 million in 2022, then crashed by 193.7% to -$12.7 million in 2023, then soared by 57.65% to -$5.4 million in 2024, then skyrocketed by 83.54% to -$884000.0 in 2025.
  • Per Business Quant, the three most recent readings for NUS's Change in Inventory are -$884000.0 (Q4 2025), -$94000.0 (Q3 2025), and -$10.9 million (Q2 2025).